Cutler Group’s Dova Pharmaceuticals, Inc. Common Stock DOVA Stock Holding History

Cutler Group’s Portfolio DOVA Stock Details DOVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-3,500	Closed	-$97K	–	4967
2019 Q3	$97K	Buy	+3,500	New	+$56.7K	0.01%	1086
2019 Q2	–	Sell	-500	Closed	-$4.76K	–	5105
2019 Q1	$4K	Sell	500 -200	-29%	-$1.62K	﹤0.01%	3125
2018 Q4	$5K	Buy	+700	New	+$11.3K	﹤0.01%	2978

Cutler Group's DOVA Position: Q4 2019 in Review

Cutler Group sold out of Dova Pharmaceuticals, Inc. Common Stock (DOVA) in Q4 2019, closing a stake of 3,500 shares — an estimated $97K sold.

Cutler Group first reported a position in DOVA in Q4 2018 and held it in 3 quarters. The position peaked at $97K in Q3 2019. 0 funds tracked by Wall St. Rank hold DOVA as of Q4 2019.

Cutler Group reported no remaining Dova Pharmaceuticals, Inc. Common Stock position as of Q4 2019 after selling out during the quarter.
Cutler Group sold 3,500 Dova Pharmaceuticals, Inc. Common Stock shares in Q4 2019, an estimated $97K.
Cutler Group first reported a position in Dova Pharmaceuticals, Inc. Common Stock in Q4 2018 and held it in 3 quarters.
Cutler Group's Dova Pharmaceuticals, Inc. Common Stock position peaked at $97K in Q3 2019.
0 funds tracked by Wall St. Rank held Dova Pharmaceuticals, Inc. Common Stock as of Q4 2019.

Based on Cutler Group's 13F filing for Q4 2019, filed 6 Feb 2020.